These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association between hyperlipidemia and microalbuminuria in essential hypertension. Campese VM; Bianchi S; Bigazzi R Kidney Int Suppl; 1999 Jul; 71():S10-3. PubMed ID: 10412727 [TBL] [Abstract][Full Text] [Related]
4. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. Bigazzi R; Bianchi S; Baldari D; Campese VM J Hypertens; 1998 Sep; 16(9):1325-33. PubMed ID: 9746120 [TBL] [Abstract][Full Text] [Related]
5. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects. Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study. Cotter J; Oliveira P; Cunha P; Polónia J Nephron Clin Pract; 2009; 113(1):c8-15. PubMed ID: 19590230 [TBL] [Abstract][Full Text] [Related]
7. Silent ischemia is more prevalent among hypertensive patients with microalbuminuria and salt sensitivity. Bianchi S; Bigazzi R; Amoroso A; Campese VM J Hum Hypertens; 2003 Jan; 17(1):13-20. PubMed ID: 12571612 [TBL] [Abstract][Full Text] [Related]
9. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Dell'Omo G; Penno G; Giorgi D; Di Bello V; Mariani M; Pedrinelli R Am J Kidney Dis; 2002 Jul; 40(1):1-8. PubMed ID: 12087554 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease. Marín R; Rodríguez P; Tranche S; Redón J; Morales-Olivas F; Galgo A; Brito MA; Mediavilla J; Lozano JV; Filozof C; J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S178-88. PubMed ID: 17130259 [TBL] [Abstract][Full Text] [Related]
11. Lowering the threshold for defining microalbuminuria: effects of a lifestyle-metformin intervention in obese "normoalbuminuric" non-diabetic subjects. Cubeddu LX; Alfieri AB; Hoffmann IS Am J Hypertens; 2008 Jan; 21(1):105-10. PubMed ID: 18091752 [TBL] [Abstract][Full Text] [Related]
12. Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients. Rodilla E; Pérez-Lahiguera F; Costa JA; González C; Miralles A; Moral D; Pascual JM Med Clin (Barc); 2009 Jan; 132(1):1-6. PubMed ID: 19174057 [TBL] [Abstract][Full Text] [Related]
13. Microalbuminuria as a marker of cardiac damage in essential hypertension. Mettimano M; Specchia ML; Migneco A; Savi L Eur Rev Med Pharmacol Sci; 2001; 5(1):31-6. PubMed ID: 11860221 [TBL] [Abstract][Full Text] [Related]
14. Microalbuminuria in essential hypertension: clinical and biochemical profile. de la Sierra A; Bragulat E; Sierra C; Gomez-Angelats E; Antonio MT; Aguilera MT; Coca A Br J Biomed Sci; 2000; 57(4):287-91. PubMed ID: 11204857 [TBL] [Abstract][Full Text] [Related]
15. Microalbuminuria in patients with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker. Bianchi S; Bigazzi R; Baldari G; Campese VM Am J Hypertens; 1991 Apr; 4(4 Pt 1):291-6. PubMed ID: 2059393 [TBL] [Abstract][Full Text] [Related]
16. [Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril]. Toblli JE; Bellido CA; Iavícoli OR; Costa M; Forcada P; Piñeiro DJ; Lerman J Medicina (B Aires); 2002; 62(6):544-50. PubMed ID: 12532688 [TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension. Berrut G; Bouhanick B; Fabbri P; Guilloteau G; Bled F; Le Jeune JJ; Fressinaud P; Marre M Clin Nephrol; 1997 Aug; 48(2):92-7. PubMed ID: 9285145 [TBL] [Abstract][Full Text] [Related]
18. Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension. Bianchi S; Bigazzi R; Nenci R; Campese VM J Nephrol; 1997; 10(6):325-33. PubMed ID: 9442446 [TBL] [Abstract][Full Text] [Related]
19. [Microalbuminuria and urinary albumin excretion: French guidelines]. Halimi JM; Hadjadj S; Aboyans V; Allaert FA; Artigou JY; Beaufils M; Berrut G; Fauvel JP; Gin H; Nitenberg A; Renversez JC; Rusch E; Valensi P; Cordonnier D; Ann Biol Clin (Paris); 2008; 66(3):277-84. PubMed ID: 18558566 [TBL] [Abstract][Full Text] [Related]
20. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade. Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]